FindTrial
Sign In

Barriers to Transition to Long-Term Follow-Up care of Childhood Cancer Survivors in China

Barriers to Transition to Long-Term Follow-Up care of Childhood Cancer Survivors in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072195
Enrollment
Unknown
Registered
2023-06-06
Start date
2023-06-06
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cancer Survivors

Interventions

questionnaire:No

Sponsors

Shanghai Jiaotong university school of medicine affiliated Shanghai children's medical center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: Children with hematological tumors need to simultaneously meet the following: 1. At least 5 years after diagnosis; 2. In remission for at least 2 years after cessation of treatment

Exclusion criteria

Exclusion criteria: Parents of children with non-hematological tumors,and the child is not satisfied with stopping the medication 1. At least 5 years after diagnosis; 2. In remission for at least 2 years after cessation of treatment. No informed consent form was signed.

Design outcomes

Primary

MeasureTime frame
Survey on Late Effect Care in China (for Caregiver);Survey on Mapping the Status in Late Effect Care in China;—

Countries

China

Contacts

Public ContactCai Jiaoyang

1678 Dongfang Road, Pudong New District, Shanghai, China

caijiaoyang@scmc.com.cn+86 136 2162 7180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026